Vaginal lubricants and moisturizers: a review into use, efficacy, and safety

References

• Portman DJ, Gass ML. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society. Climacteric 2014;17:557–63
   PubMed Web of Science ®Google Scholar
• Edwards D, Panay N. Treating vulvovaginal atrophy/genitourinary syndrome of menopause: how important is vaginal lubricant and moisturizer composition. Climacteric 2016;19:151–61
   PubMed Web of Science ®Google Scholar
• Dunn KM, Croft PR, Hackett G. Sexual problems: a study of the prevalence and need for health care in the general population. Fam Pract 1998;15:519–24
   PubMed Web of Science ®Google Scholar
• Leiblum SR, Hayes RD, Wanser RA, Nelson JS. Vaginal dryness: a comparison of prevalence and interventions in 11 countries. J Sex Med 2009;6:2425–33
   PubMed Web of Science ®Google Scholar
• Palacios S. Managing urogenital atrophy. Maturitas 2009;63:315–18
   PubMed Web of Science ®Google Scholar
• Panay N, Fenton A. Vulvovaginal atrophy-a tale of neglect. Climacteric 2014;17:1–2
   Web of Science ®Google Scholar
• Sutton KS, Boyer SC, Goldfinger C, Ezer P, Pukall CF. To lube or not to lube: experiences and perceptions of lubricant use in women with and without dyspareunia. J Sex Med 2012;9:240–50
   PubMed Web of Science ®Google Scholar
• Cordeau D, Courtois F. Sexual disorders in women with MS: assessment and management. Ann Phys Rehabil Med 2014;57:337–47
   PubMedGoogle Scholar
• Kennedy SH, Rizvi S. Sexual dysfunction, depression, and the impact of antidepressants. J Clin Psychopharmacol 2009;29:157–64
   PubMed Web of Science ®Google Scholar
• Andelloux M. Products for sexual lubrication: understanding and addressing options with your patients. Nurs Womens Health 2011;15:253–7
   PubMedGoogle Scholar
• Derzko C, Elliott S, Lam W. Management of sexual dysfunction in postmenopausal breast cancer patients taking adjuvant aromatase inhibitor therapy. Curr Oncol 2007;14:S20–S40
   PubMedGoogle Scholar
• Goldstein AT, Burrows L. Sexual pain disorders in women; 2009. Available from: http://www.issm.info/news/review-reports/sexual-pain-disorders-in-women [7 Jul 2015]
   Google Scholar
• Berman JR, Adhikari SP, Goldstein I. Anatomy and physiology of female sexual function and dysfunction: classification, evaluation and treatment options. Eur Urol 2000;38:20–9
   PubMed Web of Science ®Google Scholar
• Lev-Sagie A. Vulvar and vaginal atrophy: physiology, clinical presentation, and treatment considerations. Clin Obstet Gynecol 2015;58:476–91
   PubMed Web of Science ®Google Scholar
• The North American Menopause Society. Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society. Menopause 2013;20:888–902
   PubMed Web of Science ®Google Scholar
• Simon JA, Kokot-Kierepa M, Goldstein J, Nappi RE. Vaginal health in the United States: results from the vaginal health: insights, views & attitudes survey. Menopause 2013;20:1043–8
   PubMed Web of Science ®Google Scholar
• Sturdee DW, Panay N. Recommendations for the management of postmenopausal vaginal atrophy. Climacteric 2010;13:509–22
   PubMed Web of Science ®Google Scholar
• Panay N. Genitourinary syndrome of the menopause – dawn of a new era. Climacteric 2015;18:13–17
   PubMed Web of Science ®Google Scholar
• Lammerink EA, de Bock GH, Schroder CP, Mourits MJ. The management of menopausal symptoms in breast cancer survivors: case-based approach. Maturitas 2012;73:265–8
   PubMed Web of Science ®Google Scholar
• Faubion SS, Sood R, Kapoor E. Genitourinary syndrome of menopause: management strategies for the clinician. Mayo Clin Proc 2017;92:1842–9
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration. Nov 2018 Update on FDA warns against use of energy-based devices to perform vaginal 'rejuvenation' or vaginal cosmetic procedures: FDA safety communication. 2018. Available from: https://www.fda.gov/medical-devices/safety-communications/fda-warns-against-use-energy-based-devices-perform-vaginal-rejuvenation-or-vaginal-cosmetic
   Google Scholar
• Connor CJ, Eppsteiner EE. Vulvar contact dermatitis. Proc Obstet Gynecol 2014;4:1–14
   Google Scholar
• Amelar RD, Dubin L, Schoenfeld C. Sperm motility. Fertil Steril 1980;34:197–215
   PubMed Web of Science ®Google Scholar
• Kutteh WH, Chao CH, Ritter JO, Byrd W. Vaginal lubricants for the infertile couple: effect on sperm activity. Int J Fertil Menopausal Stud 1996;41:400–4
   PubMedGoogle Scholar
• Kabara JJ, Orth DS, Preservative Free and Self-Preserving Cosmetics and Drugs. Principles and Practice. New York: Marcel Dekker, Inc.; 1997
   Google Scholar
• Willhite LA, O'Connell MB. Urogenital atrophy: prevention and treatment. Pharmacotherapy 2001;21:464–80
   PubMed Web of Science ®Google Scholar
• Herbenick D, Reece M, Schick V, Sanders SA, Fortenberry JD. Women's use and perceptions of commercial lubricants: prevalence and characteristics in a nationally representative sample of American adults. J Sex Med 2014;11:642–52
   PubMed Web of Science ®Google Scholar
• Jozkowski KN, Herbenick D, Schick V, Reece M, Sanders SA, Fortenberry JD. Women's perceptions about lubricant use and vaginal wetness during sexual activities. J Sex Med 2013;10:484–92
   PubMed Web of Science ®Google Scholar
• World Health Organization. Use and procurement of additional lubricants for male and female condoms: WHO/UNFPA/FH1360 advisory note; 2012 [7 Jul 2015]. Available from http://apps.who.int/iris/bitstream/10665/76580/1/WHO_RHR_12.33_eng.pdf
   Google Scholar
• Adriaens E, Remon JP. Mucosal irritation potential of personal lubricants relates to product osmolality as detected by the slug mucosal irritation assay. Sex Transm Dis 2008;35:512–16
   PubMed Web of Science ®Google Scholar
• Agarwal A, Deepinder F, Cocuzza M, Short RA, Evenson DP. Effect of vaginal lubricants on sperm motility and chromatin integrity: a prospective comparative study. Fertil Steril 2008;89:375–9
   PubMed Web of Science ®Google Scholar
• Dezzutti CS, Brown ER, Moncla B, et al. Is wetter better? An evaluation of over-the-counter personal lubricants for safety and anti-HIV-1 activity. PLoS One 2012;7:448328
   Web of Science ®Google Scholar
• Fuchs EJ, Lee LA, Torbenson MS, et al. Hyperosmolar personal sexual lubricant causes epithelial damage in the distal colon: potential implication for HIV transmission. J Infect Dis 2007;195:703–10
   PubMed Web of Science ®Google Scholar
• Rossato M, Balercia G, Lucarelli G, Foresta C, Mantero F. Role of seminal osmolarity in the reduction of human sperm motility. Int J Androl 2002;25:230–5
   PubMedGoogle Scholar
• Steiner AZ, Long DL, Tanner C, Herring AH. Effect of vaginal lubricants on natural fertility. Obstet Gynecol 2012;120:44–51
   PubMed Web of Science ®Google Scholar
• Raz R. Urinary tract infection in postmenopausal women. Korean J Urol 2011;52:801–8
   PubMedGoogle Scholar
• Cunha AR, Machado RM, Palmeira-de-Oliveira A, Martinez-de Oliveira J, das Neves J, Palmeira-de-Oliveira R. Characterisation of commercially available vaginal lubricants: a safety perspective. Pharmaceutics 2014;6:530–42
   PubMedGoogle Scholar
• Harvey PW, Everett DJ. Significance of the detection of esters of p-hydroxybenzoic acid (parabens) in human breast tumours. J Appl Toxicol 2004;24:1–4
   PubMed Web of Science ®Google Scholar
• Berger KP, Kogut KR, Bradman A, et al. Personal care product use as a predictor of urinary concentrations of certain phthalates, parabens, and phenols in the HERMOSA study. J Expo Sci Environ Epidemiol 2019;29:21–32
   PubMed Web of Science ®Google Scholar
• Stoiber T; Environmental Working Group. What are parabens and why don’t they belong in cosmetics, April 9, 2019. Available from: https://www.ewg.org/californiacosmetics/parabens [Accessed 22 Aug 2020]
   Google Scholar
• Brotman RM, Ravel J, Cone RA, Zenilman JM. Rapid fluctuation of the vaginal microbiota measured by Gram stain analysis. Sex Transm Infect 2010;86:297–302
   PubMed Web of Science ®Google Scholar
• Moench TR, Mumper RJ, Hoen TE, Sun M, Cone RA. Microbicide excipients can greatly increase susceptibility to genital herpes transmission in the mouse. BMC Infect Dis 2010;10:331
   PubMed Web of Science ®Google Scholar
• Muhleisen AL, Herbst-Kralovetz MM. Menopause and the vaginal microbiome. Maturitas 2016;91:42–50
   PubMed Web of Science ®Google Scholar
• Achilles SL, Shete PB, Whaley KJ, Moench TR, Cone RA. Microbicide efficacy and toxicity tests in a mouse model for vaginal transmission of Chlamydia trachomatis. Sex Transm Dis 2002;29:655–64
   PubMed Web of Science ®Google Scholar
• Begay O, Jean-Pierre N, Abraham CJ, et al. Identification of personal lubricants that can cause rectal epithelial cell damage and enhance HIV type 1 replication in vitro. AIDS Res Hum Retroviruses 2011;27:1019–24
   PubMed Web of Science ®Google Scholar
• Nappi RE, Kotek M, Breštanský A, Giordan N, Tramentozzi E. Effectiveness of hyaluronate-based pessaries in the treatment of vulvovaginal atrophy in postmenopausal women. Climacteric 2020;23:519–24
   PubMed Web of Science ®Google Scholar
• Panay N, Palacios S, Bruyniks N, Particco M, Nappi RE. Nappi RE; EVES Study investigators. Symptom severity and quality of life in the management of vulvovaginal atrophy in postmenopausal women. Maturitas 2019;124:55–61
   PubMed Web of Science ®Google Scholar